Cart
sales@molnova.com
Human Papillomavirus (HPV) E7 protein 49-57
CAS No. 151812-18-9
Human Papillomavirus (HPV) E7 protein 49-57( —— )
Catalog No. M30294 CAS No. 151812-18-9
Human Papillomavirus (HPV) E7 protein (49-57) is the H-2d-restricted human papillomavirus (HPV) E749-57 epitope.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameHuman Papillomavirus (HPV) E7 protein 49-57
-
NoteResearch use only, not for human use.
-
Brief DescriptionHuman Papillomavirus (HPV) E7 protein (49-57) is the H-2d-restricted human papillomavirus (HPV) E749-57 epitope.
-
DescriptionHuman Papillomavirus (HPV) E7 protein (49-57) is the H-2d-restricted human papillomavirus (HPV) E749-57 epitope.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHPV
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number151812-18-9
-
Formula Weight1120.26
-
Molecular FormulaC52H77N15O13
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Arg}{Ala}{His}{Tyr}{Asn}{Ile}{Val}{Thr}{Phe}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Ding Z, et al. Cytolytic activity of the human papillomavirus type 16 E711-20 epitope-specific cytotoxic T lymphocyte is enhanced by heat shock protein 110 in HLA-A*0201 transgenic mice. Clin Vaccine Immunol. 2013 Jul;20(7):1027-33.
molnova catalog
related products
-
HPV16 E7 (86-93)
This is amino acids 86 to 93 fragment of the human papilloma virus (HPV) type 16 oncoprotein E7. This HPV16-encoded peptide has very high affinity of binding to the HLA-A*0201 molecule.This immunogenic fragment may be used in vaccines for the prevention and treatment of cervical carcinoma.
-
Human Papillomavirus...
Human Papillomavirus (HPV) E7 protein (49-57) is the H-2d-restricted human papillomavirus (HPV) E749-57 epitope.
-
Teslexivir
A first-in-class, small molecule protein-protein inhibitor of the interaction between the E1 and E2 proteins of HPV types 6 and 11.
